Spots Global Cancer Trial Database for carcinoma breast

Every month we try and update this database with for carcinoma breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.	NCT05507034	Neoplasm, Breas... Carcinoma Breas... Chronic Pain	Biomarkers	25 Years - 65 Years	Universiteit Antwerpen
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery	NCT03113825	Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas...	Investigational... AVB-620	18 Years -	Avelas Biosciences, Inc.
Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy	NCT03768492	Carcinoma Breas...	Caffeine anhydr... Lipoderm Cream ...	18 Years -	NYU Langone Health
Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast	NCT03002766	Carcinoma Breas...	Breast conserva...	18 Years -	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy	NCT01849133	Carcinoma Breas...	external fracti... intraoperative ...	48 Years - 75 Years	European Institute of Oncology
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer	NCT04790305	Carcinoma Breas... Triple-negative... Invasive Ductal...	Huaier Granule	18 Years - 70 Years	Fudan University
Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy	NCT01849133	Carcinoma Breas...	external fracti... intraoperative ...	48 Years - 75 Years	European Institute of Oncology
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs	NCT04985357	Stage III Breas... Stage IV Breast... Stage III Lung ... Stage IV Lung C... AML Multiple Myelom... Carcinoma Carcinoma, Panc... Carcinoma of Lu... Carcinoma, Non-... Carcinoma Breas... Carcinoma Prost... Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Neur... Carcinoma, Smal... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Es... Carcinoma Cervi... Carcinoma, Thym... Carcinoma, Duct... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Malignant Pleur... Malignant Ascit... Mesothelioma Cholangiocarcin...		18 Years -	Travera Inc
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer	NCT04790305	Carcinoma Breas... Triple-negative... Invasive Ductal...	Huaier Granule	18 Years - 70 Years	Fudan University
Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast	NCT03002766	Carcinoma Breas...	Breast conserva...	18 Years -	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)	NCT05461430	Pleural Effusio... Ascites, Malign... Carcinoma Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Rena... Carcinoma, Smal... Carcinoma, Non-... Carcinoma, Panc... Carcinoma, Neur... Carcinoma, Thym... Carcinoma, Panc... Carcinoma Breas... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Es... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Cholangiocarcin... Melanoma Mesothelioma Pancreatic Canc...		18 Years -	Travera Inc
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery	NCT03113825	Primary Invasiv... Carcinoma Breas... Breast Cancer F... Carcinoma, Duct... Stage II Breast... Stage I Breast ... Stage III Breas...	Investigational... AVB-620	18 Years -	Avelas Biosciences, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: